The clinical challengesA 42-year-old man was referred for recurrent fever and purpuric rash that began at age 8 with persistent elevation in acute-phase reactants and mild hypogammaglobulinemia. When he was nine years old, he had an episode of sudden neurosensorial hearing loss, and over time, he developed severe ulcers in both lower limbs, where a skin biopsy led to a histologic diagnosis of polyarteritis nodosa. Treatment with steroids, azathioprine, methotrexate, dapsone, oral cyclophosphamide, and rituximab had failed to control his symptoms. At the age of 32, he had a stroke, and at 34 years, he experienced intestinal infarction due to mesenteric vasculitis, requiring chronic high-dose steroid therapy. A genetic cause was suspected due to the early onset and multidrug inefficacy. We tested the enzymatic activity of adenosine deaminase 2 (ADA2), finding complete absence of activity. Sanger sequencing of ADA2 subsequently confirmed the diagnosis of ADA2 deficiency (DADA2), with compound heterozygosity for p.Thr360Ile and p.Ser483Ile mutations. Anti-tumor necrosis factor (anti-TNF) treatment with etanercept was started, resulting in a prompt resolution of systemic inflammation and a normalization of the clinical picture. Steroid treatment was rapidly discontinued. The patient remains asymptomatic on anti-TNF monotherapy.